India has stepped back plans to halt exports of the anti-malarial drug hydroxychloroquine after the Trump administration threatened to retaliate against the planned move. India is the world’s largest producer of hydroxychloroquine, which President Trump has repeatedly encouraged Americans to try and touted as a “game changer” in treating COVID-19 symptoms, despite medical experts warning more tests were needed.